HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice.

Abstract
Monascorubrin (an azaphilone derivative) was isolated from Monascus anka, 'Monascus pigment', a natural pigment of food additivies, was extracted from Monasucs spp., and chaetoviridin A, one of the azaphilones, was isolated from Chaetomium globosum var. flavo-viridae. Application of 1 microgram of 12-O-tetradecanoylphorbol-13-acetate (TPA), a tumor promoting agent, to the mouse ear resulted in induction of inflammation. Among monascorubrin and related compounds assayed, monascorubrin, chaetoviridin A and its related compounds inhibited the inflammatory activity of TPA in mice. The 50% inhibitory dose of these compounds for TPA-induced inflammation was 0.4-1.5 mumol. Furthermore, monascorubrin (2 mumol), chaetoviridin A (2 mumol) and Monascus pigment (1 mg) markedly suppressed the promoting effect of TPA (1 microgram) on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene (50 micrograms). It is assumed that the inhibition of tumor promotion by monascorubrin, chaetoviridin A and Monascus pigment is due to anti-inflammatory activity.
AuthorsK Yasukawa, M Takahashi, S Natori, K Kawai, M Yamazaki, M Takeuchi, M Takido
JournalOncology (Oncology) 1994 Jan-Feb Vol. 51 Issue 1 Pg. 108-12 ISSN: 0030-2414 [Print] Switzerland
PMID8265094 (Publication Type: Journal Article)
Chemical References
  • Anticarcinogenic Agents
  • Benzopyrans
  • 9,10-Dimethyl-1,2-benzanthracene
  • Dinitrofluorobenzene
  • Tetradecanoylphorbol Acetate
Topics
  • 9,10-Dimethyl-1,2-benzanthracene (toxicity)
  • Animals
  • Anticarcinogenic Agents (pharmacology)
  • Benzopyrans (pharmacology)
  • Dinitrofluorobenzene (toxicity)
  • Female
  • Hypersensitivity, Delayed
  • Inflammation
  • Mice
  • Mice, Inbred ICR
  • Skin Neoplasms (chemically induced, prevention & control)
  • Tetradecanoylphorbol Acetate (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: